Shares of Abbott India were trading in the green and 5% higher on 10 May after the company announced its quarterly earnings for January-March. 

The company reported a 24% year-on-year increase in its net profit for the quarter under review at Rs 287 crore from Rs 231 crore reported in the same quarter of the previous fiscal year. 

The company’s revenue during the quarter stood at Rs 1,439 crore, marking a 7.1% YoY increase from Rs 1,343.1 crore reported in the same quarter last year. 

Its earnings before interest, taxes, depreciation and amortisation (EBITDA) grew by 17.6% YoY to Rs 329.5 crore during the quarter from Rs 280.1 crore reported in the year-ago quarter. The EBITDA margins expanded by 200 basis points to 22.9% in Q4FY24 from 20.9% in Q4FY23. 

The board of directors of the company have also declared a final dividend of Rs 410 per share for the fiscal year 2023-24. The record date for determining the members’ eeligibilityfor the final dividend has been set as 19 July 2024.

The company is based in Mumbai and provides medications across various therapeutic areas, including gastroenterology, women’s health, metabolic disorders, cardiology, and primary care.

At 1:12 pm, the shares of Abbott India were trading 3.74% higher at Rs 26,519.80 on NSE.